Paul Glaucoma Implant Versus Ahmed Glaucoma Valve in Childhood Glaucoma

Last updated: April 2, 2023
Sponsor: Al Watany Eye Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Glaucoma

Treatment

N/A

Clinical Study ID

NCT05797350
AlWatanyEyeH
  • Ages < 18
  • All Genders

Study Summary

A randomized controlled trial comparing the efficacy and safety of Paul glaucoma implant and Ahmed glaucoma valve in refractory childhood glaucoma patients

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Childhood glaucoma patients (whether primary or secondary) including Juvenile openangle glaucoma if the age at the time of surgery was ≤18 years.
  • The included patients are those with refractory glaucoma who require a tube to controltheir intraocular pressure.

Exclusion

Exclusion Criteria:

  • Any patient with incomplete data or has a follow-up less than 1 year will be excludedfrom the study.

Study Design

Total Participants: 24
Study Start date:
September 01, 2022
Estimated Completion Date:
December 01, 2024

Study Description

A prospective randomized controlled trial was conducted at Al Watany Eye Hospital in Egypt. Patients with refractory primary or secondary childhood glaucoma who glaucoma specialist has decided to perform a tube implant to control their intraocular pressure are randomized to receive either Paul or Ahmed glaucoma drainage devices.

Patients will be followed up for at least one year during which the following data are collected.

Age, sex, laterality, preoperative and postoperative intraocular pressure and glaucoma medications at 1,3,6, 9, and 12 months visits. Any intraoperative or postoperative complications will be recorded

Connect with a study center

  • Maadi eye subspeciality center

    Cairo,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.